82 related articles for article (PubMed ID: 22377647)
1. Galectin-7 as a marker of cholesteatoma residue and its detection during surgery by an immunofluorescent method--a preliminary study.
Takagi D; Hato N; Okada M; Hakuba N; Gyo K; Shigemoto K; Toda T; Ogasawara M; Kameda K
Otol Neurotol; 2012 Apr; 33(3):396-9. PubMed ID: 22377647
[TBL] [Abstract][Full Text] [Related]
2. The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas.
Sheikholeslam-Zadeh R; Decaestecker C; Delbrouck C; Danguy A; Salmon I; Zick Y; Kaltner H; Hassid S; Gabius HJ; Kiss R; Choufani G
Laryngoscope; 2001 Jun; 111(6):1042-7. PubMed ID: 11404618
[TBL] [Abstract][Full Text] [Related]
3. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
Ayache S; Tramier B; Strunski V
Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
[TBL] [Abstract][Full Text] [Related]
4. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
5. Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Choufani G; Ghanooni R; Decaestecker C; Delbrouck K; Simon P; Schüring MP; Zick Y; Hassid S; Gabius HJ; Kiss R
Laryngoscope; 2001 Sep; 111(9):1656-62. PubMed ID: 11568623
[TBL] [Abstract][Full Text] [Related]
6. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
7. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
8. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
Durko M; Kaczmarczyk D
Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
[TBL] [Abstract][Full Text] [Related]
9. [Surgery of cholesteatoma of the ear canal].
Jahnke K; Lieberum B
Laryngorhinootologie; 1995 Jan; 74(1):46-9. PubMed ID: 7888023
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
11. High-resolution microendoscope images of middle ear cholesteatoma and surrounding tissue: evaluation of interobserver concordance.
Bradley J; Jiang N; Levy L; Richards-Kortum R; Sikora A; Smouha E
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):654-8. PubMed ID: 24415492
[TBL] [Abstract][Full Text] [Related]
12. Reversible canal wall down mastoidectomy for acquired cholesteatomas: preliminary results.
McElveen JT; Chung AT
Laryngoscope; 2003 Jun; 113(6):1027-33. PubMed ID: 12782816
[TBL] [Abstract][Full Text] [Related]
13. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
[TBL] [Abstract][Full Text] [Related]
14. Immune cell profile in invasive cholesteatomas: preliminary findings.
Hussein MR; Sayed RH; Abu-Dief EE
Exp Mol Pathol; 2010 Apr; 88(2):316-23. PubMed ID: 20045407
[TBL] [Abstract][Full Text] [Related]
15. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
17. Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
Ghanooni R; Decaestecker C; Simon P; Gabius HJ; Hassid S; Choufani G
Hear Res; 2006 Apr; 214(1-2):7-16. PubMed ID: 16513304
[TBL] [Abstract][Full Text] [Related]
18. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
Chao WY; Huang CC
Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
[TBL] [Abstract][Full Text] [Related]
19. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
Caffier PP; Marzahn U; Franke A; Sudhoff H; Jovanovic S; Haisch A; Sedlmaier B
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1179-88. PubMed ID: 18253741
[TBL] [Abstract][Full Text] [Related]
20. [Reconstruction of the auditory canal wall with bone chips from the temporal squama--preliminary results].
Gehrking E; Wollenberg B; Frenzel H
Laryngorhinootologie; 2007 Jun; 86(6):436-42. PubMed ID: 17265389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
